Protecting indigenous medicinal plants, herbal formulations, and traditional healing systems under modern intellectual property laws requires balancing patent exclusions under Section 3(p) of the Patents Act, 1970 with proactive prior art documentation in the Traditional Knowledge Digital Library and statutory benefit-sharing under the Biological Diversity Act, 2002.
Intellectual Property Frameworks and Traditional Knowledge in India
India possesses an extensive heritage of traditional medical knowledge codified in ancient systems such as Ayurveda, Unani, Siddha, and Sowa-Rigpa, as well as thousands of undocumented tribal and community healing practices. For decades, international corporations and research institutions attempted to commercialize and patent herbal remedies derived from indigenous Indian plants without attributing credit or sharing economic returns with local knowledge custodians.
This vulnerability to biopiracy highlighted the pressing need to adapt intellectual property rights (IPR) to protect community-held heritage. Traditional knowledge differs fundamentally from western intellectual property concepts: while conventional patents reward individual or corporate inventors for novel, commercially applicable inventions with time-limited exclusivity, traditional knowledge is developed collectively, held in common, and passed down across generations.
Section 3(p) of the Patents Act: Barring Traditional Knowledge Monopolies
To defend against wrongful patent claims, the Indian Parliament enacted specific safeguards within the Patents Act, 1970. The most critical defense is Section 3(p), introduced through statutory amendments to align India's patent regime with public health and heritage priorities:
- Section 3(p) Mandate: The provision explicitly states that an invention which in effect is traditional knowledge or which is an aggregation or duplication of known properties of traditionally known component or components is not patentable.
- Novelty and Inventive Step Standards: Because traditional medicinal uses already exist in the public domain, simple herbal preparations lack the statutory requirements of novelty and non-obviousness.
- Scope for Modern Innovations: Section 3(p) does not prohibit all pharmaceutical research involving natural products. Where an applicant develops a genuinely novel chemical isolate, an inventive extraction process, or a non-obvious synergistic therapeutic formulation that demonstrates clear clinical efficacy beyond traditional preparations, patent protection remains accessible.
Defensive Protection: The Traditional Knowledge Digital Library
India pioneered defensive intellectual property protection by creating the Traditional Knowledge Digital Library (TKDL) in 2001, a joint collaboration between the Council of Scientific and Industrial Research (CSIR) and the Ministry of AYUSH. The TKDL digitizes ancient Sanskrit, Arabic, Persian, Urdu, and Tamil medical texts into structured patent application formats across multiple international languages (English, French, German, Japanese, and Spanish).
By granting international patent examiners direct access to this prior art database, the TKDL enables patent offices in the United States, Europe, Japan, and Canada to identify and reject invalid patent applications before grants are issued. This institutional defense was prompted by historic legal battles, including India's successful revocation of the United States patent on the wound-healing properties of turmeric (Curcuma longa) and the European Patent Office revocation of the patent on the fungicidal properties of neem (Azadirachta indica).
In addition to physical plant research, modern legal compliance demands strict digital governance. Learn more about our cyber security, data protection and data privacy legal services for technological and regulatory operations.
The Biological Diversity Act and Access and Benefit Sharing
Defensive patent databases operate alongside the Biological Diversity Act, 2002, which implements India's commitments under the United Nations Convention on Biological Diversity (CBD) and the Nagoya Protocol. The statutory regime establishes a three-tier administrative structure:
- National Biodiversity Authority (NBA): Regulates foreign individuals and commercial entities seeking access to Indian biological resources and associated knowledge for research or commercial utilization.
- State Biodiversity Boards (SBB): Oversees domestic commercial utilization and issues approvals for equitable benefit sharing.
- Biodiversity Management Committees (BMC): Formed at the local panchayat and municipal levels to maintain People's Biodiversity Registers (PBRs) and document indigenous flora, fauna, and ethno-medicinal practices.
- Access and Benefit Sharing (ABS): Mandates that commercial entities utilizing biological resources must share a percentage of revenue or provide community benefits (infrastructure, capacity building, technology transfer) with local conservationists and traditional healers.
Copyright, Performers' Rights, and Media Convergence
Beyond patents and biodiversity, intellectual property protection extends to traditional cultural expressions, folk music, oral narratives, and performative traditions under the Copyright Act, 1957. The digital era has complicated the enforcement of copyright, bringing new challenges regarding digital sampling, broadcast licensing, and fair dealing in educational broadcasting.
Artists, performers, and traditional knowledge holders require clear contractual and statutory protection to prevent unauthorized digital reproduction, commercial exploitation, and dilution of artistic identity across convergent digital media platforms.
UPES National Seminar: Themes, Sub-Themes, and Academic Engagement
Addressing these critical legal intersections, the College of Legal Studies at the University of Petroleum and Energy Studies (UPES), Dehradun, convened a National Seminar titled "Intellectual Property Rights on Copyright, Patent and Protection of Indigenous Medicinal Plants, Herbs, Roots and Practices." Located in the Himalayan foothills of Uttarakhand, UPES provided an academic platform for legal scholars, botanists, social scientists, and practitioners.
The seminar structured its academic deliberations around key thematic areas:
- Protection and conservation of indigenous medicinal flora, roots, and plant varieties.
- Coding, decoding, and scientific validation of traditional medicinal formulations from plant products.
- Sui generis legal models for community-held traditional knowledge and geographical indications.
- Constitutional and statutory protections for artists, performers, and creators in modern jurisprudence.
- Cross-border enforcement challenges of copyright in an era of media convergence and digital distribution.
- Emerging forms of copyright licensing, digital fair use, and technological protection measures.
Scholarly engagement in national symposiums helps bridge the gap between grassroots herbal practitioners, statutory authorities, and international patent systems. For related academic resources and criminal jurisprudence analysis, explore our class notes on criminal law unit I covering statutory offences and legal procedure.